FBIOP.PFD (Fortress Biotech) Short-Term Capital Lease Obligation : $2.16 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Fortress Biotech Short-Term Capital Lease Obligation?

Fortress Biotech's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was $2.16 Mil.

Fortress Biotech's quarterly Short-Term Capital Lease Obligation increased from Sep. 2024 ($2.51 Mil) to Dec. 2024 ($2.62 Mil) but then declined from Dec. 2024 ($2.62 Mil) to Mar. 2025 ($2.16 Mil).

Fortress Biotech's annual Short-Term Capital Lease Obligation increased from Dec. 2022 ($2.45 Mil) to Dec. 2023 ($2.52 Mil) and increased from Dec. 2023 ($2.52 Mil) to Dec. 2024 ($2.62 Mil).

Fortress Biotech Short-Term Capital Lease Obligation Historical Data

The historical data trend for Fortress Biotech's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortress Biotech Short-Term Capital Lease Obligation Chart

Fortress Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.85

2.10

2.45

2.52

2.62

Fortress Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															2.60	2.48	2.51	2.62	2.16

Fortress Biotech Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Fortress Biotech Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Fortress Biotech's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Fortress Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortress Biotech Inc (NAS:FBIOP.PFD) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

FBIO:USA CNB0.PFD:Germany

Address

1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154

Website

https://www.fortressbiotech.com

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.